LLBH Private Wealth Management »

Halozyme Therapeutics shares owned by LLBH Private Wealth Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by LLBH Private Wealth Management from 13F filings

Historical chart of LLBH Private Wealth Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by LLBH Private Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by LLBH Private Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $296k 8.0k 36.96
2023-09-30 $229k 6.0k 38.20
2023-06-30 $216k 6.0k 36.07
2018-03-31 $1.2M 60k 19.58
2017-12-31 $1.2M 60k 20.20
2017-09-30 $1.0M 60k 17.37
2017-06-30 $774k 60k 12.82
2017-03-31 $2.0M 156k 12.96